135 related articles for article (PubMed ID: 15933064)
21. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
Fu K; Iqbal J; Chan WC
Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
[TBL] [Abstract][Full Text] [Related]
22. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
[TBL] [Abstract][Full Text] [Related]
24. Molecular characteristics of diffuse large-B-cell lymphoma.
Magrath I
N Engl J Med; 2002 Jun; 346(25):1998-9. PubMed ID: 12075062
[No Abstract] [Full Text] [Related]
25. Subtype preference of the BCL6397G/C polymorphism in germinal-center and non-germinal-center subtypes of diffuse large B-cell lymphoma.
Berglund M; Amini RM; Book M; Rosenquist R; Roos G; Thunberg U
Blood; 2006 Nov; 108(10):3623-4. PubMed ID: 17085720
[No Abstract] [Full Text] [Related]
26. Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.
Nielsen KR; Steffensen R; Bendtsen MD; Rodrigo-Domingo M; Baech J; Haunstrup TM; Bergkvist KS; Schmitz A; Boedker JS; Johansen P; Dybkaeær K; Boeøgsted M; Johnsen HE
PLoS One; 2015; 10(10):e0139329. PubMed ID: 26448050
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide induced remission of refractory diffuse large B-Cell Lymphoma post-allogeneic SCT.
Tueger S; Chen FE; Ahsan G; McDonald V; Andrews VE; Madrigal JA; Kazmi MA
Haematologica; 2006 Jun; 91(6 Suppl):ECR16. PubMed ID: 16785122
[TBL] [Abstract][Full Text] [Related]
28. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiling of lymphoma.
Copur MS; Ledakis P; Bolton M
N Engl J Med; 2002 Oct; 347(17):1376-7; author reply 1376-7. PubMed ID: 12400094
[No Abstract] [Full Text] [Related]
30. [Diffuse large B-cell lymphoma expressing surface immunoglobulin heavy chain (Ig alpha) and lacking light chains].
Ando M; Isobe Y; Sasaki M; Sugimoto K; Ando J; Oshimi K
Rinsho Ketsueki; 2005 Jul; 46(7):492-5. PubMed ID: 16440740
[TBL] [Abstract][Full Text] [Related]
31. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.
Hahn T; Wolff SN; Czuczman M; Fisher RI; Lazarus HM; Vose J; Warren L; Watt R; McCarthy PL;
Biol Blood Marrow Transplant; 2001; 7(6):308-31. PubMed ID: 11464975
[No Abstract] [Full Text] [Related]
32. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.
Bielska M; Borowiec M; Jesionek-Kupnicka D; Braun M; Bojo M; Pastorczak A; Kalinka-Warzocha E; Prochorec-Sobieszek M; Robak T; Warzocha K; Młynarski W; Lech-Marańda E
Int J Hematol; 2017 Dec; 106(6):794-800. PubMed ID: 28879630
[TBL] [Abstract][Full Text] [Related]
33. Molecular heterogeneity of diffuse large B-cell lymphoma.
Gascoyne RD
Hematol J; 2004; 5 Suppl 3():S144-8. PubMed ID: 15190297
[No Abstract] [Full Text] [Related]
34. [Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].
Sakai R; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1105-8. PubMed ID: 16440771
[TBL] [Abstract][Full Text] [Related]
35. Non-Hodgkin's lymphoma as an exemplar of the effects of genetics and genomics.
Calzone KA; Lea DH; Masny A
J Nurs Scholarsh; 2006; 38(4):335-43. PubMed ID: 17181081
[TBL] [Abstract][Full Text] [Related]
36. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
[TBL] [Abstract][Full Text] [Related]
37. Genetic strategies to individualize supportive care.
McLeod HL
J Clin Oncol; 2002 Jun; 20(12):2765-7. PubMed ID: 12065551
[No Abstract] [Full Text] [Related]
38. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
39. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
Hiraga J; Katsumi A; Iwasaki T; Abe A; Kiyoi H; Matsushita T; Kinoshita T; Naoe T
Leukemia; 2007 Aug; 21(8):1846-7. PubMed ID: 17443219
[No Abstract] [Full Text] [Related]
40. BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma.
Hu LL; Wang XX; Chen X; Chang J; Li C; Zhang Y; Yang J; Jiang W; Zhuang SM
Carcinogenesis; 2007 Aug; 28(8):1740-4. PubMed ID: 17494054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
